A Physician's Report from Capitol Hill: The Coalition for Metabolic Health Briefing on Nutrition, Chronic Disease, and GLP-1s
By
Dr. Tro
Summary
A physician recounts their experience participating in the Coalition for Metabolic Health's first Capitol Hill briefing on nutrition and chronic disease in the era of GLP-1 medications. Co-sponsored by Reps. Lloyd Smucker and Sharice Davids, the event brought together lawmakers, medical experts, researchers, policy professionals, and patients with lived experience of chronic disease to discuss the intersection of metabolic health, nutrition policy, and emerging treatments.
Source
Twitter / XA Physician's Report from Capitol Hill: The Coalition for Metabolic Health Briefing on Nutrition, Chronic Disease, and GLP-1stoward.healthKey quotes
· 3 pulledLast month, I had the opportunity to travel to Washington, D.C., to participate in the Coalition for Metabolic Health's first Capitol Hill briefing on nutrition and chronic disease in the era of GLP-1s.
Co-sponsored by Rep. Lloyd Smucker (PA-11) and Rep. Sharice Davids (KS-03), the briefing brought together members of Congress and their staffs, physicians, researchers, policy experts, and individuals with lived experience of chronic disease.
While I was there to share my experience as a physician, I was really representing something much bigger: the thousands of patients in the Tow
You might also wanna read
National Psoriasis Foundation Review Examines GLP-1 Receptor Agonists for Psoriasis with Metabolic Comorbidities
This review from the US National Psoriasis Foundation Medical Board provides an evidence-informed narrative synthesis on GLP-1 receptor agon
doi.org·1mo ago
Coalition for Metabolic Health Launches with $50 Million to Address America's Chronic Disease Crisis
The Coalition for Metabolic Health (CMH) has launched with $50 million in seed funding from the Baszucki family to address America's metabol
coalitionformetabolichealth.org·10mo ago
Research Suggests Heart Disease, Kidney Disease and Type 2 Diabetes May Be One Condition Treatable with GLP-1 Drugs
The article discusses the emerging medical concept of "CKM syndrome" (cardiometabolic kidney syndrome), which suggests that heart disease, k
scientificamerican.com·6mo ago
Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us
Pfizer's Early 1990s Decision to Abandon Promising GLP-1 Therapy Development
The article reveals previously untold history about early GLP-1 drug development in the late 1980s and early 1990s. The author was part of w
statnews.com·6mo ago
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p
theverge.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.